Centrum für Integrierte Onkologie Aachen Bonn Köln Düsseldorf (CIO ABCD)

Research facility


Location: Aachen, Bonn, Köln, Düsseldorf, Germany (DE) DE

ISNI: -

ROR: https://ror.org/04f2wf871

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Telomere Length Is Associated With Adverse Atrial Remodeling in Patients With Atrial Fibrillation (2025) Pradhan K, Neupane B, Niehues P, Kirschner M, Beier F, Kuo CC, Hilbold EA, et al. Journal article The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression. (2025) Saal J, Eckstein M, Ritter M, Brossart P, Hölzel M, Grünwald V, Klümper N Journal article Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer (2024) Denkert C, Schneeweiss A, Rey J, Karn T, Hattesohl A, Weber KE, Rachakonda S, et al. Journal article Benchmarking whole exome sequencing in the German network for personalized medicine (2024) Menzel M, Martis-Thiele M, Goldschmid H, Ott A, Romanovsky E, Siemanowski-Hrach J, Seillier L, et al. Journal article The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer (2024) Klümper N, Grünwald V, Hartmann A, Hölzel M, Eckstein M Journal article Mitbetreuung der Angehörigen von Patient:innen mit einer nicht heilbaren Krebserkrankung im Erkrankungsverlauf (2024) Oechsle K, Berendt J, Gebert T, Heckel M, Hentschel L, Hornemann B, Jentschke E, et al. Journal article SOP – Mitbetreuung der Angehörigen von Patient:innen mit einer nicht heilbaren Krebserkrankung in der Sterbephase (2024) Oechsle K, Berendt J, Gebert T, Heckel M, Hentschel L, Hornemann B, Jentschke E, et al. Journal article mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) (2024) Hofheinz RD, Herrle F, Dechow T, von Weikersthal LF, Welslau M, Lettmaier S, Burkart C, et al. Journal article NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer (2024) Klümper N, Tran NK, Zschäbitz S, Hahn O, Büttner T, Roghmann F, Bolenz C, et al. Journal article High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma (2024) Klümper N, Cox A, Eckstein M, Kuppe C, Ritter M, Brossart P, Luetkens J, et al. Journal article
1 2 3